"Using Epigallocatechin Gallate (EGCG) and Cognitive Training to Modulate Cognitive Performance in Patients With Fragile X Syndrome (TESFX)"

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

June 11, 2013

Primary Completion Date

July 31, 2015

Study Completion Date

October 31, 2015

Conditions
Fragile X Syndrome
Interventions
DIETARY_SUPPLEMENT

EGCG

Life Extension, Mega Green Tea Extract Decaffeinated is a dietary supplement containing EGCG extract (45% EGCG). This extract contains 98% total polyphenols and 45% epigallocatechin-3-gallate (EGCG). EGCG administration in Down syndrome patients will result in an improvement of their cognitive performance.

DIETARY_SUPPLEMENT

Placebo

Same capsules containing rice flour. No active treatment is given.

OTHER

Cognitive training

Feskits program 3 times per week (1 hour/session) Patients in this arm of the trial carried out computerized online training drawn from the Feskits program (www.feskits.com), chosen to have attention, memory and executive function components. Specifically the sessions included the following exercises: sustained attention, attention/perception, working memory, auditory and visual memory, executive function and language.

Trial Locations (1)

08003

Parc de Salut MAR, Hospital del Mar Medical Research Institute-IMIM, Barcelona

All Listed Sponsors
lead

Parc de Salut Mar

OTHER

NCT01855971 - "Using Epigallocatechin Gallate (EGCG) and Cognitive Training to Modulate Cognitive Performance in Patients With Fragile X Syndrome (TESFX)" | Biotech Hunter | Biotech Hunter